Concepedia
Statistics
Publications
15
Citations
905
H-Index
14
Active since
1995
Affiliations
Thomas Jefferson University(Current)
GlaxoSmithKline (United States)
Research Triangle Park Foundation
Princess Margaret Cancer Centre
University of Pennsylvania
Richard A. Brigandi is an author at Thomas Jefferson University specializing in medicine, parasitology, and pathogenesis.
Top concepts
MedicinePathologyParasitologyPathogenesisPharmacotherapyAllergyBiologySurgeryHepatitisSymbiosis
Publications per year
1995–2019
A Novel Hypoxia-Inducible Factor−Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial
Richard A. Brigandi, Brendan M. Johnson, Coreen Oei et al. · American Journal of Kidney Diseases · 2016 · 159 citations · Full text
The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma
Andrew Spencer, Sung‐Soo Yoon, Simon J. Harrison et al. · Blood · 2014 · 135 citations · Full text
Strongyloides stercoralis:Eosinophil-Dependent Immune-Mediated Killing of Third Stage Larvae in BALB/cByJ Mice
Harris L. Rotman, Wiboonchai Yutanawiboonchai, Richard A. Brigandi et al. · Experimental Parasitology · 1996 · 103 citations · Full text
Farglitazar Lacks Antifibrotic Activity in Patients With Chronic Hepatitis C Infection
John G. McHutchison, Zachary Goodman, Keyur Patel et al. · Gastroenterology · 2009 · 92 citations
Hepatology, Viral Hepatitis, Medicine +7
Strongyloides stercoralis: Protective Immunity to Third-Stage Larvae in BALB/cByJ Mice
David Abraham, Harris L. Rotman, Hanna Haberstroh et al. · Experimental Parasitology · 1995 · 83 citations · Full text
1–5 of 15